A Randomized, Open Label, Cross-over, Phase 1 Trial to Investigate the Pharmacokinetics in Multi-dose and the Food Effect in Single-dose of Pelubiprofen IR and Pelubiprofen SR in Healthy Male Volunteers
Latest Information Update: 11 Feb 2014
At a glance
- Drugs Pelubiprofen (Primary)
- Indications Back pain; Fever; Osteoarthritis; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Daewon Pharmaceutical
- 13 Jan 2014 Status changed to completed as reported by ClinicalTrials.gov record.
- 11 Jun 2013 New trial record